3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
127
Phase 4
14
Phase 2
11
Phase 3
5
Phase EARLY_PHASE1
4
Phase 2/3
2
Phase 1
2
Phase 1/2
1
Status
Recruiting
3
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
2
Breast
1
Conditions
Breast Neoplasms
40
Neoplasms
36
Prostatic Neoplasms
32
Colorectal Neoplasms
22
Carcinoma, Non-Small-Cell Lung
22
Leukemia, Myeloid, Acute
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasm Metastasis
14
Polycystic Ovary Syndrome
13
Lung Neoplasms
13
Stomach Neoplasms
12
Multiple Myeloma
11
Carcinoma, Hepatocellular
11
Recurrence
10
Pancreatic Neoplasms
10
Urinary Bladder Neoplasms
9
Lymphoma
9
Leukemia
9
Myelodysplastic Syndromes
8
Motor Activity
8
Head and Neck Neoplasms
8
Liver Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Brain Neoplasms
7
Pain
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Interventions
penclomedine
1
Exercise
1
Exenatide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Completed
×
Obesity
×
Clear all
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts
NCT00393172
2019-11-01
WISER
University of Minnesota
Phase 2/3
Completed
400 enrolled